Tuberculosis News and Research

Latest Tuberculosis News and Research

HP, mPedigree Network introduce life-saving service to fight counterfeit drugs in Africa

HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.

6 Dec 2010

IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

The Infectious Disease Research Institute has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority. IDRI's work will focus on development of adjuvant formulations with options up to $8.5 million over three years when further development and manufacture of priority candidates are approved by the agency.

4 Dec 2010

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

The Infectious Disease Research Institute (IDRI) today announced it has received a $790,200 grant from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services. The grant enables technology transfer between IDRI and the Cantacuzino National Institute of Research and Development for Microbiology and Immunology (Bucharest, Romania), with the goal of producing a pandemic flu vaccine.

4 Dec 2010

HIV/AIDS opinions

"Promising scientific developments to prevent AIDS, not just treat its victims, have sparked hope among health officials, researchers and advocacy groups struggling to control the epidemic. Unfortunately, the global recession and soaring deficits in advanced nations have made it unlikely that sufficient money will be available to fully seize the new opportunities," according to a New York Times editorial, which postures, "[s]ome agonizing choices will have to be made."

4 Dec 2010

Biomagnetics updates prototype bench top version of IOBS biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced that an updated prototype bench top version of the Integrated Optical Biosensor, originally developed at Los Alamos for research purposes, is now complete.

3 Dec 2010

White House marks World AIDS Day

Commemorating World AIDS Day on Wednesday President Barack Obama called for continuing to fight HIV/AIDS domestically and abroad, Agence France-Presse reports (12/1).

2 Dec 2010

Research: Environmental bacteria compromises effectiveness of BCG vaccine

A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others.

2 Dec 2010

Regular, low-cost preventive medication can protect people with HIV from TB

Children and adults living with HIV can be protected from one of their deadliest threats - tuberculosis (TB) - with a regular, low-cost preventive medication according to new guidelines launched today by the WHO. Of the nearly two million AIDS-related deaths each year, a quarter of them are associated with TB.

2 Dec 2010

Biomagnetics identifies second biomarker for tuberculosis assay

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, today announced the identification of a second biomarker for development of a tuberculosis assay.

2 Dec 2010

USA today examines why aid for Haiti goes unspent

Ten months after the magnitude-7 earthquake that killed 230,000 people and destroyed at least 60% of Haiti's capital city, Port-au-Prince, some relief agencies have not spent the bulk of the donations they raised after the disaster.

2 Dec 2010

Report analyzes global health funding trends, predicts lower funding growth

A report from the Institute for Health Metrics and Evaluation (IHME) finds that the recent global economic downturn "hasn't quelled generous government and private donors from giving record amounts to improve global health," but the analysis also revealed "that growth in funding is beginning to taper off, cut by more than half between 2008 and 2010," the Seattle Times' "The Business of Giving" blog reports (Heim, 11/30).

2 Dec 2010

U.N. says PMTCT of HIV is achievable; efforts must target millions currently 'falling through the cracks'

A generation of babies could be born free of AIDS if the international community stepped up efforts to provide universal access to HIV prevention, treatment and social protection, the United Nations said on Tuesday, Reuters reports.

2 Dec 2010

Donors donate record amounts for global health despite the worst economic crisis

The worst global economic crisis in decades has not stopped public and private donors from giving record amounts of money to health assistance for developing countries, according to a new report by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

1 Dec 2010

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Anacor Pharmaceuticals, the University of California San Francisco (UCSF) Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center (NYBC) today announced the establishment of a research and development collaboration to discover new drug therapies for the treatment of river blindness (onchocerciasis), a parasitic disease that is the second leading cause of infectious blindness worldwide, and is most prevalent in Africa.

1 Dec 2010

Research shows anti-microbial medications lead to acute liver failure

New research shows that anti-microbial medications are a common cause of drug-induced liver injury (DILI) leading to acute liver failure (ALF), with women and minorities disproportionately affected.

1 Dec 2010

Golimumab with methotrexate improves markers of inflammation and structural damage in RA patients

Magnetic resonance imaging (MRI) analyses from two Phase 3 clinical trials showed that once every four week subcutaneous injections of golimumab 50 mg plus methotrexate resulted in statistically significant improvements in markers of inflammation and structural damage in patients with active rheumatoid arthritis (RA) compared with placebo plus methotrexate.

30 Nov 2010

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

There are some encouraging signs in the epic battle against AIDS and HIV infections. But those bright spots dim considerably in the face of the fact that about 7,100 people a day become infected.

30 Nov 2010

HP, Clinton Health Access Initiative collaborate to improve HIV testing and treatment of infants in Kenya

HP today announced an alliance with the Clinton Health Access Initiative (CHAI) that will provide structural and systemic improvements in testing and treating more than 120,000 infants exposed to HIV in Kenya each year.

30 Nov 2010

NIAID scientists confirm antiviral activity of two lead compounds against HPV

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds showed excellent in vitro antiviral activity and no cellular toxicity at dose levels tested for Human Papillomavirus (HPV).

30 Nov 2010

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck today reported initial results from the Phase III study investigating the efficacy and safety of a treatment regimen including ISENTRESS® (raltegravir) Tablets once daily in treatment-naïve adult patients infected with HIV-1. ISENTRESS is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve and treatment-experienced adults.

29 Nov 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

HP, mPedigree Network introduce life-saving service to fight counterfeit drugs in Africa

IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

HIV/AIDS opinions

Biomagnetics updates prototype bench top version of IOBS biosensor

White House marks World AIDS Day

Research: Environmental bacteria compromises effectiveness of BCG vaccine

Regular, low-cost preventive medication can protect people with HIV from TB

Biomagnetics identifies second biomarker for tuberculosis assay

USA today examines why aid for Haiti goes unspent

Report analyzes global health funding trends, predicts lower funding growth

U.N. says PMTCT of HIV is achievable; efforts must target millions currently 'falling through the cracks'

Donors donate record amounts for global health despite the worst economic crisis

Anacor, UCSF and NYBC collaborate to discover drug therapies for river blindness

Research shows anti-microbial medications lead to acute liver failure

Golimumab with methotrexate improves markers of inflammation and structural damage in RA patients

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

HP, Clinton Health Access Initiative collaborate to improve HIV testing and treatment of infants in Kenya

NIAID scientists confirm antiviral activity of two lead compounds against HPV

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in